SlideShare a Scribd company logo
Introduction to Pharmacology
Name : Yukta Wankhede
Programme : MSc MT Cardiac Care Technology
Content
Principle of Drug Action
• The Drug administration
• The Pharmacokinetic phase
• The Pharmacodynamic phase
Administration of Drugs
• Enteral
• Parenteral
Principle of Drug Action : The Drug Administration
• Most of the drug can be administered by different routes. Drug
and patient-related factors determine the selection of routes for
drug administration.
• These factors are :
a. Characteristics of the drug
b. Emergency / routine use
c. Condition of the patient (unconsious, vomiting & diarrhoea)
d. Age of the patient
e. Associated diseases
The Drug Administration
Pharmacokinetics
• Definition
Pharmacokinetics id derived from 2 words:
Pharmaco meaning drug and Kinesis meaning movement.
In short , it is what the body does to the drug.
It includes Absorption (A), Distribution (D), Metabolism (M)
and Excretion (E).
Pharmacokinetics
Pharmacokinetics as a drug’s journey through
the body, during which it passes through four
different phases: absorption, distribution,
metabolism, and excretion (ADME). The four
steps are:
• Absorption: Describes how the drug moves
from the site of administration to the site of
action.
• Distribution: Describes the journey of the drug
through the bloodstream to various tissues of
the body.
• Metabolism: Describes the process that
breaks down the drug.
• Excretion: Describes the removal of the drug
from the body.
Pharmacokinetics
Absorption
• Absorption is the movement of a drug from its site of administration
to the bloodstream. The rate and extent of drug absorption depend
on multiple factors, such as:
• Route of administration
• The formulation and chemical properties of a drug
• Drug-food interactions
• The administration (e.g., oral, intravenous, inhalation) of a drug
influences bioavailability, the fraction of the active form of a drug that
enters the bloodstream and successfully reaches its target site.
• When a drug is given intravenously, absorption is not required, and
bioavailability is 100% because the active form of the medicine is
delivered immediately to the systemic circulation. However, orally
administered medications have incomplete absorption and result in
less drug delivery to the site of action. For example, many orally
administered drugs are metabolized within the gut wall or the liver
before reaching the systemic circulation. This is referred to as first-
pass metabolism, which reduces drug absorption.
Pharmacokinetics
Distribution
• The process of drug distribution is important because it can affect
how much drug ends up in the active sites, and thus drug efficacy
and toxicity. A drug will move from the absorption site to tissues
around the body, such as brain tissue, fat, and muscle. Many factors
could influence this, such as blood flow, lipophilicity, molecular size,
and how the drug interacts with the components of blood, like
plasma proteins.
• For example, a drug like warfarin is highly protein-bound, which
means only a small percentage of the drug is free in the bloodstream
to exert its therapeutic effects. If a highly protein-bound drug is given
in combination with warfarin, it could displace warfarin from the
protein-binding site and increase the amount that enters the
bloodstream.
• Additionally, there are anatomical barriers found in certain organs
like the blood-brain barrier, preventing certain drugs from going into
brain tissue. Drugs with certain characteristics, like high lipophilicity,
small size, and molecular weight will be better able to cross the
blood brain barrier.
Pharmacokinetics
Metabolism
• Cytochrome enzymes (CYP450) are responsible for the biotransformation or
metabolism of about 70-80% of all drugs in clinical use.
What are some factors that affect drug metabolism?
• Genetics can impact whether someone metabolizes drugs more quickly or
slowly.
• Age can impact liver function; the elderly have reduced liver function and
may metabolize drugs more slowly, increasing risk of intolerability, and
newborns or infants have immature liver function and may require special
dosing considerations.
• Drug interactions can lead to decreased drug metabolism by enzyme
inhibition or increased drug metabolism by enzyme induction.
Pharmacokinetics
Metabolism
• Cytochrome enzymes (CYP450) are responsible for the biotransformation or metabolism of about 70-80% of all drugs in
clinical use.
• When a drug is metabolized through CYP450 enzymes, it results in inactive metabolites, which have none of the original
drug's pharmacologic activity. However, certain medications, like codeine, are inactive and become converted in the body
into a pharmacologically active drug. These are commonly referred to as prodrugs.
• As you can imagine, having genetic variations in CYP2D6, the metabolic pathway for codeine, can have significant clinical
consequences. Usually, CYP2D6 poor metabolizers (PMs) have higher serum levels of active drugs. In codeine, PMs have
higher serum levels of the inactive drug, which could result in inefficacy. Conversely, ultra-rapid metabolizers (UMs) will
transform codeine to morphine extremely quickly, resulting in toxic morphine levels.
• The FDA added a black box warning to the codeine drug label, stating that respiratory depression and death have occurred
in children who received codeine following a tonsillectomy and/or adenoidectomy and who have evidence of being a
CYP2D6 UM.
Pharmacokinetics
Excretion
• Elimination involves both the metabolism and the excretion of the
drug through the kidneys, and to a much smaller degree, into the
bile.
• Excretion into the urine through the kidneys is one of the most
important mechanisms of drug removal.
• Many factors affect excretion, such as:
• Direct renal dysfunction, which could prolong the half-life of certain
drugs and necessitate dose adjustments.
• Age, which can contribute to differing rates of excretion and impact
dosing of medications.
• Pathologies that impact renal blood flow, such as congestive heart
failure and liver disease can make drug excretion less efficient
• Whether it’s a patient who just had gastric bypass surgery, a
CYP2D6 poor metabolizer, or a patient with renal dysfunction, an
individual’s characteristics affect these four processes, which can
ultimately influence medication selection.
• Pharmacodynamics is the aspects relating to ‘what the
drug does to the body’.
• It is the study of drugs – their mechanism of action ,
pharmacological actions and adverse effect.
Pharmacodynamics
Introduction to pharmacology, Route of Drug Administration , Pharmacokinetics and Pharmacodynamics.
Introduction to pharmacology, Route of Drug Administration , Pharmacokinetics and Pharmacodynamics.
Introduction to pharmacology, Route of Drug Administration , Pharmacokinetics and Pharmacodynamics.

More Related Content

What's hot

Routes of administrations
Routes of administrationsRoutes of administrations
Routes of administrations
S.G.S.S. COLLEGE OF PHARMACY, MANUR
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administration
mizan00
 
5.routes of drug administration
5.routes of drug administration5.routes of drug administration
5.routes of drug administration
Khyber Medical university
 
2 routes of administration
2 routes of administration2 routes of administration
2 routes of administration
bernard kathewera
 
Drug adminstration routes
Drug adminstration routesDrug adminstration routes
Drug adminstration routes
serag35
 
[Pharma] routes of drug administration
[Pharma] routes of drug administration[Pharma] routes of drug administration
[Pharma] routes of drug administrationMuhammad Ahmad
 
Routes of administration
Routes of administrationRoutes of administration
Routes of administration
SANI SINGH
 
Routes of administration of drug
Routes of administration of drugRoutes of administration of drug
Routes of administration of drug
Genesis Institute of Pharmacy, Radhanagari.
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administration
Pravin Prasad
 
7. Routes Of Drug Administration
7. Routes Of Drug Administration7. Routes Of Drug Administration
7. Routes Of Drug Administration
Hemed Sahes
 
Routes of Drug administration - Pharmacology
Routes of Drug administration - PharmacologyRoutes of Drug administration - Pharmacology
Routes of Drug administration - Pharmacology
Harshit Jadav
 
Route of administration of drugs
Route of administration of drugsRoute of administration of drugs
Route of administration of drugs
Muhammed Bishir
 
routes of drug adminstration
routes of drug adminstrationroutes of drug adminstration
routes of drug adminstration
Safia Al-rezami
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administration
Dr.Shivalinge Gowda KP
 
Route of drug administration
Route of drug administrationRoute of drug administration
Route of drug administration
BikashAdhikari26
 
Route of Drug Administaration
Route of Drug AdministarationRoute of Drug Administaration
Route of Drug Administaration
amoluborade
 
Routes of administration...pharmacology
Routes of administration...pharmacologyRoutes of administration...pharmacology
Routes of administration...pharmacology
Rajeshwari Netha
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administrationMd. Jakiul Islam
 
parenteral route of drug administration
parenteral route of drug administrationparenteral route of drug administration
parenteral route of drug administration
DHUMAL KULDIP S
 
Sanjib
SanjibSanjib
Sanjib
SANJIB YADAV
 

What's hot (20)

Routes of administrations
Routes of administrationsRoutes of administrations
Routes of administrations
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administration
 
5.routes of drug administration
5.routes of drug administration5.routes of drug administration
5.routes of drug administration
 
2 routes of administration
2 routes of administration2 routes of administration
2 routes of administration
 
Drug adminstration routes
Drug adminstration routesDrug adminstration routes
Drug adminstration routes
 
[Pharma] routes of drug administration
[Pharma] routes of drug administration[Pharma] routes of drug administration
[Pharma] routes of drug administration
 
Routes of administration
Routes of administrationRoutes of administration
Routes of administration
 
Routes of administration of drug
Routes of administration of drugRoutes of administration of drug
Routes of administration of drug
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administration
 
7. Routes Of Drug Administration
7. Routes Of Drug Administration7. Routes Of Drug Administration
7. Routes Of Drug Administration
 
Routes of Drug administration - Pharmacology
Routes of Drug administration - PharmacologyRoutes of Drug administration - Pharmacology
Routes of Drug administration - Pharmacology
 
Route of administration of drugs
Route of administration of drugsRoute of administration of drugs
Route of administration of drugs
 
routes of drug adminstration
routes of drug adminstrationroutes of drug adminstration
routes of drug adminstration
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administration
 
Route of drug administration
Route of drug administrationRoute of drug administration
Route of drug administration
 
Route of Drug Administaration
Route of Drug AdministarationRoute of Drug Administaration
Route of Drug Administaration
 
Routes of administration...pharmacology
Routes of administration...pharmacologyRoutes of administration...pharmacology
Routes of administration...pharmacology
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administration
 
parenteral route of drug administration
parenteral route of drug administrationparenteral route of drug administration
parenteral route of drug administration
 
Sanjib
SanjibSanjib
Sanjib
 

Similar to Introduction to pharmacology, Route of Drug Administration , Pharmacokinetics and Pharmacodynamics.

Therapuetic drug monitoring
Therapuetic drug monitoringTherapuetic drug monitoring
Therapuetic drug monitoring
Sarah jaradat
 
Toxicology
ToxicologyToxicology
Toxicology
PortiaCenteno
 
DRUG ACTION- NURSING FOUNDATIONS.pptx
DRUG ACTION- NURSING FOUNDATIONS.pptxDRUG ACTION- NURSING FOUNDATIONS.pptx
DRUG ACTION- NURSING FOUNDATIONS.pptx
Sandhya C
 
2 - DRUG METABOLISM 2023.pptx
2 -  DRUG METABOLISM 2023.pptx2 -  DRUG METABOLISM 2023.pptx
2 - DRUG METABOLISM 2023.pptx
EmmyKardianasari
 
understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics...
understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics...understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics...
understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics...
MaryRoseFraga
 
Pharmacology for rehablitition nursing in geriartic
Pharmacology for rehablitition nursing in geriarticPharmacology for rehablitition nursing in geriartic
Pharmacology for rehablitition nursing in geriartic
Kashan University of Medical Sciences and Health Services
 
Pharmacology part 2
Pharmacology part 2Pharmacology part 2
Pharmacology part 2
NkosinathiManana2
 
Introduction to pharmacology
Introduction to pharmacologyIntroduction to pharmacology
Introduction to pharmacology
Afkar432
 
Pharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adultsPharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adults
Safaa Ali
 
Toxicokinetics toxicology pre-clinical pharmacology
Toxicokinetics  toxicology  pre-clinical pharmacologyToxicokinetics  toxicology  pre-clinical pharmacology
Toxicokinetics toxicology pre-clinical pharmacology
Dilip Kawane
 
1 Pharmacology Pharmacokinetics
1 Pharmacology   Pharmacokinetics1 Pharmacology   Pharmacokinetics
1 Pharmacology Pharmacokinetics
Laurence Hattersley
 
General Pharmacology for Physiotherapists
General Pharmacology for PhysiotherapistsGeneral Pharmacology for Physiotherapists
General Pharmacology for Physiotherapists
Dr. Sanjib Kumar Das
 
General Pharmacology part 02.pptx
General Pharmacology part 02.pptxGeneral Pharmacology part 02.pptx
General Pharmacology part 02.pptx
MAYUR HARAL
 
PKPD NEW.pptx
PKPD NEW.pptxPKPD NEW.pptx
PKPD NEW.pptx
ssuser3c47e3
 
SESSION 1 PHARMA.pptx at ghhhjjyggggghhh
SESSION 1 PHARMA.pptx at ghhhjjyggggghhhSESSION 1 PHARMA.pptx at ghhhjjyggggghhh
SESSION 1 PHARMA.pptx at ghhhjjyggggghhh
benalphaemma
 
PHARMACOKINETIC
PHARMACOKINETICPHARMACOKINETIC
PHARMACOKINETIC
SanjogBam
 
introduction in clinical pharmacology. Main principles of clinical pharmacolo...
introduction in clinical pharmacology. Main principles of clinical pharmacolo...introduction in clinical pharmacology. Main principles of clinical pharmacolo...
introduction in clinical pharmacology. Main principles of clinical pharmacolo...
MOHAMMAD NOUR AL SAEED
 
General pharmacology intro
General pharmacology introGeneral pharmacology intro
General pharmacology intro
Jehan Zeb Khan
 
General pharmacology intro
General pharmacology introGeneral pharmacology intro
General pharmacology intro
Jehan Zeb Khan
 

Similar to Introduction to pharmacology, Route of Drug Administration , Pharmacokinetics and Pharmacodynamics. (20)

Therapuetic drug monitoring
Therapuetic drug monitoringTherapuetic drug monitoring
Therapuetic drug monitoring
 
Toxicology
ToxicologyToxicology
Toxicology
 
DRUG ACTION- NURSING FOUNDATIONS.pptx
DRUG ACTION- NURSING FOUNDATIONS.pptxDRUG ACTION- NURSING FOUNDATIONS.pptx
DRUG ACTION- NURSING FOUNDATIONS.pptx
 
2 - DRUG METABOLISM 2023.pptx
2 -  DRUG METABOLISM 2023.pptx2 -  DRUG METABOLISM 2023.pptx
2 - DRUG METABOLISM 2023.pptx
 
understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics...
understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics...understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics...
understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics...
 
Pharmacology for rehablitition nursing in geriartic
Pharmacology for rehablitition nursing in geriarticPharmacology for rehablitition nursing in geriartic
Pharmacology for rehablitition nursing in geriartic
 
Pharmacology part 2
Pharmacology part 2Pharmacology part 2
Pharmacology part 2
 
Introduction to pharmacology
Introduction to pharmacologyIntroduction to pharmacology
Introduction to pharmacology
 
Pharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adultsPharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adults
 
Toxicokinetics toxicology pre-clinical pharmacology
Toxicokinetics  toxicology  pre-clinical pharmacologyToxicokinetics  toxicology  pre-clinical pharmacology
Toxicokinetics toxicology pre-clinical pharmacology
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
1 Pharmacology Pharmacokinetics
1 Pharmacology   Pharmacokinetics1 Pharmacology   Pharmacokinetics
1 Pharmacology Pharmacokinetics
 
General Pharmacology for Physiotherapists
General Pharmacology for PhysiotherapistsGeneral Pharmacology for Physiotherapists
General Pharmacology for Physiotherapists
 
General Pharmacology part 02.pptx
General Pharmacology part 02.pptxGeneral Pharmacology part 02.pptx
General Pharmacology part 02.pptx
 
PKPD NEW.pptx
PKPD NEW.pptxPKPD NEW.pptx
PKPD NEW.pptx
 
SESSION 1 PHARMA.pptx at ghhhjjyggggghhh
SESSION 1 PHARMA.pptx at ghhhjjyggggghhhSESSION 1 PHARMA.pptx at ghhhjjyggggghhh
SESSION 1 PHARMA.pptx at ghhhjjyggggghhh
 
PHARMACOKINETIC
PHARMACOKINETICPHARMACOKINETIC
PHARMACOKINETIC
 
introduction in clinical pharmacology. Main principles of clinical pharmacolo...
introduction in clinical pharmacology. Main principles of clinical pharmacolo...introduction in clinical pharmacology. Main principles of clinical pharmacolo...
introduction in clinical pharmacology. Main principles of clinical pharmacolo...
 
General pharmacology intro
General pharmacology introGeneral pharmacology intro
General pharmacology intro
 
General pharmacology intro
General pharmacology introGeneral pharmacology intro
General pharmacology intro
 

More from Yukta Wankhede

VenoArterila ECMO - 006.pptx
VenoArterila ECMO - 006.pptxVenoArterila ECMO - 006.pptx
VenoArterila ECMO - 006.pptx
Yukta Wankhede
 
HEART FAILURE.pptx
HEART FAILURE.pptxHEART FAILURE.pptx
HEART FAILURE.pptx
Yukta Wankhede
 
Severe Aortic Stenosis with Ischemic Heart Disease. (Management of TAVI) - Pa...
Severe Aortic Stenosis with Ischemic Heart Disease. (Management of TAVI) - Pa...Severe Aortic Stenosis with Ischemic Heart Disease. (Management of TAVI) - Pa...
Severe Aortic Stenosis with Ischemic Heart Disease. (Management of TAVI) - Pa...
Yukta Wankhede
 
FETAL ECHOCARDIOGRAPHY-006.pptx
FETAL ECHOCARDIOGRAPHY-006.pptxFETAL ECHOCARDIOGRAPHY-006.pptx
FETAL ECHOCARDIOGRAPHY-006.pptx
Yukta Wankhede
 
Development of Heart (Embryology)
Development of Heart (Embryology)Development of Heart (Embryology)
Development of Heart (Embryology)
Yukta Wankhede
 
Bundle Branch Block
Bundle Branch BlockBundle Branch Block
Bundle Branch Block
Yukta Wankhede
 
Left ventricular diastolic dysfunction in echocardiography
Left ventricular diastolic dysfunction in echocardiographyLeft ventricular diastolic dysfunction in echocardiography
Left ventricular diastolic dysfunction in echocardiography
Yukta Wankhede
 
Drug and electrolytes effect on ECG
Drug and electrolytes effect on ECGDrug and electrolytes effect on ECG
Drug and electrolytes effect on ECG
Yukta Wankhede
 

More from Yukta Wankhede (8)

VenoArterila ECMO - 006.pptx
VenoArterila ECMO - 006.pptxVenoArterila ECMO - 006.pptx
VenoArterila ECMO - 006.pptx
 
HEART FAILURE.pptx
HEART FAILURE.pptxHEART FAILURE.pptx
HEART FAILURE.pptx
 
Severe Aortic Stenosis with Ischemic Heart Disease. (Management of TAVI) - Pa...
Severe Aortic Stenosis with Ischemic Heart Disease. (Management of TAVI) - Pa...Severe Aortic Stenosis with Ischemic Heart Disease. (Management of TAVI) - Pa...
Severe Aortic Stenosis with Ischemic Heart Disease. (Management of TAVI) - Pa...
 
FETAL ECHOCARDIOGRAPHY-006.pptx
FETAL ECHOCARDIOGRAPHY-006.pptxFETAL ECHOCARDIOGRAPHY-006.pptx
FETAL ECHOCARDIOGRAPHY-006.pptx
 
Development of Heart (Embryology)
Development of Heart (Embryology)Development of Heart (Embryology)
Development of Heart (Embryology)
 
Bundle Branch Block
Bundle Branch BlockBundle Branch Block
Bundle Branch Block
 
Left ventricular diastolic dysfunction in echocardiography
Left ventricular diastolic dysfunction in echocardiographyLeft ventricular diastolic dysfunction in echocardiography
Left ventricular diastolic dysfunction in echocardiography
 
Drug and electrolytes effect on ECG
Drug and electrolytes effect on ECGDrug and electrolytes effect on ECG
Drug and electrolytes effect on ECG
 

Recently uploaded

Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
chanes7
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Dr. Vinod Kumar Kanvaria
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
tarandeep35
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
deeptiverma2406
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
Krisztián Száraz
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
Wasim Ak
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
kimdan468
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 

Recently uploaded (20)

Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 

Introduction to pharmacology, Route of Drug Administration , Pharmacokinetics and Pharmacodynamics.

  • 1. Introduction to Pharmacology Name : Yukta Wankhede Programme : MSc MT Cardiac Care Technology
  • 2. Content Principle of Drug Action • The Drug administration • The Pharmacokinetic phase • The Pharmacodynamic phase Administration of Drugs • Enteral • Parenteral
  • 3. Principle of Drug Action : The Drug Administration • Most of the drug can be administered by different routes. Drug and patient-related factors determine the selection of routes for drug administration. • These factors are : a. Characteristics of the drug b. Emergency / routine use c. Condition of the patient (unconsious, vomiting & diarrhoea) d. Age of the patient e. Associated diseases
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13. Pharmacokinetics • Definition Pharmacokinetics id derived from 2 words: Pharmaco meaning drug and Kinesis meaning movement. In short , it is what the body does to the drug. It includes Absorption (A), Distribution (D), Metabolism (M) and Excretion (E).
  • 14. Pharmacokinetics Pharmacokinetics as a drug’s journey through the body, during which it passes through four different phases: absorption, distribution, metabolism, and excretion (ADME). The four steps are: • Absorption: Describes how the drug moves from the site of administration to the site of action. • Distribution: Describes the journey of the drug through the bloodstream to various tissues of the body. • Metabolism: Describes the process that breaks down the drug. • Excretion: Describes the removal of the drug from the body.
  • 15. Pharmacokinetics Absorption • Absorption is the movement of a drug from its site of administration to the bloodstream. The rate and extent of drug absorption depend on multiple factors, such as: • Route of administration • The formulation and chemical properties of a drug • Drug-food interactions • The administration (e.g., oral, intravenous, inhalation) of a drug influences bioavailability, the fraction of the active form of a drug that enters the bloodstream and successfully reaches its target site. • When a drug is given intravenously, absorption is not required, and bioavailability is 100% because the active form of the medicine is delivered immediately to the systemic circulation. However, orally administered medications have incomplete absorption and result in less drug delivery to the site of action. For example, many orally administered drugs are metabolized within the gut wall or the liver before reaching the systemic circulation. This is referred to as first- pass metabolism, which reduces drug absorption.
  • 16. Pharmacokinetics Distribution • The process of drug distribution is important because it can affect how much drug ends up in the active sites, and thus drug efficacy and toxicity. A drug will move from the absorption site to tissues around the body, such as brain tissue, fat, and muscle. Many factors could influence this, such as blood flow, lipophilicity, molecular size, and how the drug interacts with the components of blood, like plasma proteins. • For example, a drug like warfarin is highly protein-bound, which means only a small percentage of the drug is free in the bloodstream to exert its therapeutic effects. If a highly protein-bound drug is given in combination with warfarin, it could displace warfarin from the protein-binding site and increase the amount that enters the bloodstream. • Additionally, there are anatomical barriers found in certain organs like the blood-brain barrier, preventing certain drugs from going into brain tissue. Drugs with certain characteristics, like high lipophilicity, small size, and molecular weight will be better able to cross the blood brain barrier.
  • 17. Pharmacokinetics Metabolism • Cytochrome enzymes (CYP450) are responsible for the biotransformation or metabolism of about 70-80% of all drugs in clinical use. What are some factors that affect drug metabolism? • Genetics can impact whether someone metabolizes drugs more quickly or slowly. • Age can impact liver function; the elderly have reduced liver function and may metabolize drugs more slowly, increasing risk of intolerability, and newborns or infants have immature liver function and may require special dosing considerations. • Drug interactions can lead to decreased drug metabolism by enzyme inhibition or increased drug metabolism by enzyme induction.
  • 18. Pharmacokinetics Metabolism • Cytochrome enzymes (CYP450) are responsible for the biotransformation or metabolism of about 70-80% of all drugs in clinical use. • When a drug is metabolized through CYP450 enzymes, it results in inactive metabolites, which have none of the original drug's pharmacologic activity. However, certain medications, like codeine, are inactive and become converted in the body into a pharmacologically active drug. These are commonly referred to as prodrugs. • As you can imagine, having genetic variations in CYP2D6, the metabolic pathway for codeine, can have significant clinical consequences. Usually, CYP2D6 poor metabolizers (PMs) have higher serum levels of active drugs. In codeine, PMs have higher serum levels of the inactive drug, which could result in inefficacy. Conversely, ultra-rapid metabolizers (UMs) will transform codeine to morphine extremely quickly, resulting in toxic morphine levels. • The FDA added a black box warning to the codeine drug label, stating that respiratory depression and death have occurred in children who received codeine following a tonsillectomy and/or adenoidectomy and who have evidence of being a CYP2D6 UM.
  • 19. Pharmacokinetics Excretion • Elimination involves both the metabolism and the excretion of the drug through the kidneys, and to a much smaller degree, into the bile. • Excretion into the urine through the kidneys is one of the most important mechanisms of drug removal. • Many factors affect excretion, such as: • Direct renal dysfunction, which could prolong the half-life of certain drugs and necessitate dose adjustments. • Age, which can contribute to differing rates of excretion and impact dosing of medications. • Pathologies that impact renal blood flow, such as congestive heart failure and liver disease can make drug excretion less efficient • Whether it’s a patient who just had gastric bypass surgery, a CYP2D6 poor metabolizer, or a patient with renal dysfunction, an individual’s characteristics affect these four processes, which can ultimately influence medication selection.
  • 20.
  • 21. • Pharmacodynamics is the aspects relating to ‘what the drug does to the body’. • It is the study of drugs – their mechanism of action , pharmacological actions and adverse effect. Pharmacodynamics